Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 1,726,300 | 2,003,700 | 1,596,200 | 1,116,760 | 1,441,390 |
| Cost of Goods | 408,320 | 443,520 | 399,620 | 378,330 | 388,810 |
| Gross Profit | 1,319,640 | 1,352,190 | 1,239,060 | 1,255,800 | 1,051,490 |
| Operating Expenses | 934,700 | 1,008,110 | 820,210 | 824,360 | 761,840 |
| Operating Income | 383,600 | 552,590 | 376,990 | -85,600 | 291,550 |
| Other Income | 34,220 | -143,190 | 56,320 | 504,080 | -13,190 |
| Pre-tax Income | 417,820 | 409,400 | 433,310 | 418,480 | 278,360 |
| Income Tax | 117,040 | 116,600 | 129,960 | 125,660 | 83,390 |
| Net Income Continuous | 300,000 | 297,000 | 302,000 | 291,000 | 195,000 |
| Net Income | $300,000 | $297,000 | $302,000 | $291,000 | $195,000 |
| EPS Basic Total Ops | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 |
| EPS Basic Continuous Ops | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 |
| EPS Diluted Total Ops | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 |
| EPS Diluted Continuous Ops | 0.05 | 0.05 | 0.05 | 0.05 | 0.03 |
| EBITDA(a) | $383,600 | $912,440 | $376,990 | $-85,600 | $291,550 |